Literature DB >> 19015355

Nalidixic acid disk for laboratory detection of ciprofloxacin resistance in Neisseria meningitidis.

Rocío Enríquez1, Raquel Abad, Celia Salcedo, Julio A Vázquez.   

Abstract

Recently the CLSI recommended a disk diffusion method and breakpoints for meningococci which include breakpoints derived for nalidixic acid which serve as surrogate markers for gyrase A mutations associated with diminished fluoroquinolone susceptibility. This study presents the application of this methodology to a panel of 57 meningococcal strains isolated in Spain that include all levels of susceptibility to ciprofloxacin. In conclusion, the most useful method to predict isolates with gyrA mutations that decrease the activity of fluoroquinolones is the use of 30-microg nalidixic acid disks.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19015355      PMCID： PMC2630652          DOI： 10.1128/AAC.00531-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  6 in total

1.  A blood isolate of Neisseria meningitidis showing reduced susceptibility to quinolones in Hong Kong.

Authors:  Y W Chu; T K M Cheung; V Tung; F Tiu; J Lo; R Lam; R Lai; K K Wong
Journal:  Int J Antimicrob Agents       Date:  2007-04-03       Impact factor: 5.283

2.  Resistance testing of meningococci: the recommendations of the European Monitoring Group on Meningococci.

Authors:  Julio A Vázquez
Journal:  FEMS Microbiol Rev       Date:  2006-11-24       Impact factor: 16.408

3.  Multilaboratory evaluation of disk diffusion antimicrobial susceptibility testing of Neisseria meningitidis isolates.

Authors:  James H Jorgensen; Sharon A Crawford; Letitia C Fulcher; Anita Glennen; Susan M Harrington; Jana Swenson; Ruth Lynfield; Patrick R Murray; Fred C Tenover
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

4.  Emergence of fluoroquinolone-resistant Neisseria meningitidis--Minnesota and North Dakota, 2007-2008.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2008-02-22       Impact factor: 17.586

5.  Fluoroquinolone resistance in Neisseria meningitidis in Spain.

Authors:  Rocío Enríquez; Raquel Abad; Celia Salcedo; Sonia Pérez; Julio A Vázquez
Journal:  J Antimicrob Chemother       Date:  2007-11-20       Impact factor: 5.790

6.  Ciprofloxacin-resistant Neisseria meningitidis, Delhi, India.

Authors:  Smita Singhal; Kedar P Purnapatre; Vandana Kalia; Smita Dube; Deepti Nair; Monorama Deb; Pushpa Aggarwal; Sunil Gupta; Dilip J Upadhyay; Ashok Rattan; V Samuel Raj
Journal:  Emerg Infect Dis       Date:  2007-10       Impact factor: 6.883
  6 in total
  3 in total

Review 1.  Resistance surveillance studies: a multifaceted problem--the fluoroquinolone example.

Authors:  A Dalhoff
Journal:  Infection       Date:  2012-03-30       Impact factor: 3.553

2.  gyrA ser83 mutation among fluoroquinolone-resistant Salmonella enterica serovars from enteric fever patients in tertiary care hospital, Kathmandu.

Authors:  Prashanna Adhikari; Roshani Maharjan; Subash Paudel; Bikram Malla; Pradeep Kumar Shah; Anup Bastola; Upendra Thapa Shrestha
Journal:  BMC Microbiol       Date:  2022-02-10       Impact factor: 3.605

3.  Molecular detection of fluoroquinolone-resistant Neisseria meningitidis by using mismatched PCR-restriction fragment length polymorphism technique.

Authors:  Yusuke Ota; Reina Okada; Hideyuki Takahashi; Ryoichi Saito
Journal:  Front Cell Infect Microbiol       Date:  2022-08-02       Impact factor: 6.073
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.